Targeting epigenetically maladapted vascular niche alleviates liver fibrosis in nonalcoholic steatohepatitis

Abstract excerpt

17 cells to the liver. Pharmacological targeting of HDAC2 and DNMT1 alleviated fibrosis in a minipig NASH model. We conclude that epigenetically reprogrammed vascular adaptation contributes to liver fibrosis. Targeting of a vascular adaptation node might block maladaptive vascularization to promote liver regeneration in NASH.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Liver Disease and Transplantation
• Share to Liver Disease Diagnosis and Treatment
• Share to Liver physiology and pathology